ALPS ADVISORS INC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 159 filers reported holding HERON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$1,717,000
-5.6%
115,864
-6.3%
0.02%
+4.2%
Q2 2020$1,819,000
-58.2%
123,652
-10.1%
0.02%
-17.2%
Q3 2018$4,354,000
+8.0%
137,559
+32.6%
0.03%
+11.5%
Q2 2018$4,030,000
+69.6%
103,723
+20.5%
0.03%
+36.8%
Q1 2018$2,376,000
+117.4%
86,077
+42.5%
0.02%
+137.5%
Q4 2017$1,093,00060,3980.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders